1. GESTO-MAP-H: A Preeclampsia Outcome Prediction Model using HDP Gestosis Score, Mean Arterial Pressure and Serum Homocysteine - a Retrospective Randomized Case Control Pilot Study.
- Author
-
Elangovan, Janane, @ Phoornima, D. Sumeethra, Devi, T. A. Aruna, and Anuradha, G.
- Subjects
- *
PREECLAMPSIA , *HOMOCYSTEINE , *PREDICTION models , *PILOT projects , *MATERNAL mortality - Abstract
Background: Hypertensive disorders of pregnancy (HDP) affect approximately 10% of pregnancies and remain a significant contributor to maternal mortality. Current predictive tools lack both cost-effectiveness and diagnostic accuracy. This study aims to develop a cost-effective prediction model for preeclampsia outcomes utilizing the HDP Gestosis score, Mean Arterial Pressure (MAP), and serum homocysteine levels. Methods: Conducted at the Department of Obstetrics and Gynaecology, Government Medical College and Hospital, Tiruppur, a tertiary care facility in South India, this retrospective randomized control pilot study involved 60 patients. Patients were categorized retrospectively into low, medium, and high-risk groups based on HDP Gestosis score. Mean arterial pressure at 20-24 weeks gestation and serum homocysteine levels were recorded. Results: Analysis of data from 60 patients revealed varying diagnostic accuracies: HDP Gestosis score alone (71.67%), mean arterial pressure alone (55%), and serum homocysteine levels alone (55%). Serum homocysteine levels demonstrated the highest positive predictive value (96.67%) and were significantly elevated in the preeclampsia group compared to the low-risk group (p<0.0001). The combined GESTO-MAP-H model showed moderate positive correlation (r=0.6) and a cutoff value of 100 exhibited 93.3% sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy in predicting preeclampsia-related complications. Conclusion: While prevention remains a future goal, early prediction and identification of preeclampsia, coupled with timely delivery, are crucial in reducing maternal morbidity and mortality. GESTO-MAP-H emerges as a promising, economical, user-friendly predictive tool, aiding in standardized decision-making to mitigate preeclampsia-related complications. [ABSTRACT FROM AUTHOR]
- Published
- 2024